Judith Feld - Jul 26, 2022 Form 3 Insider Report for Ontrak, Inc. (OTRK)

Role: Chief Medical Officer
Signature: /s/ Judith Feld
Stock symbol: OTRK
Transactions as of: Jul 26, 2022
Transactions value $: $0
Form type: 3
Date filed: 8/5/2022, 04:46 PM
Next filing: Aug 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OTRK	Common Stock						2.85K	Jul 26, 2022	by 401(k) Plan	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	OTRK	Option (right to buy)							Jul 26, 2022	Ontrak, Inc. Common Stock	18.5K	$1.73	Direct	F1, F3
holding	OTRK	Option (right to buy)							Jul 26, 2022	Ontrak, Inc. Common Stock	1K	$5.74	Direct	F1, F4
holding	OTRK	Restricted Stock Unit							Jul 26, 2022	Ontrak, Inc. Common Stock	2K		Direct	F1, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 26,2022, Ms. Feld became the Chief Medical Officer of the Company.
F2	As of August 4, 2022, Ms. Feld has acquired 2,854.67 shares of the Company's common stock under the Company's 401(k) plan.
F3	25% of these options vest one year from the date of grant and the remaining options vest in 12 equal quarterly installments thereafter over the next three years.
F4	20% of these options vest one year from the date of grant and the remaining options vest in 16 equal quarterly installments on the last day of each quarter beginning January 1, 2023 over the next four years.
F5	Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting, or, in the complete and sole discretion of the Company, a cash payment equal to the fair market value of one share of common stock for each vested RSU.
F6	The RSU's vest over five years as follows: 40% vest on the second anniversary of the grant date and 20% vest on the third, fourth and fifth anniversaries of the grant date subject to Ms. Feld's continued employment with the Company.